AxoGen (AXGN)
(Real Time Quote from BATS)
$14.14 USD
-0.23 (-1.60%)
Updated Sep 25, 2024 02:21 PM ET
2-Buy of 5 2
D Value A Growth C Momentum B VGM
Balance Sheet
Fiscal Year End for AxoGen, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 37 | 55 | 90 | 111 | 103 |
Receivables | 25 | 22 | 18 | 18 | 17 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 23 | 19 | 17 | 13 | 14 |
Other Current Assets | 3 | 2 | 2 | 4 | 2 |
Total Current Assets | 88 | 98 | 127 | 145 | 135 |
Net Property & Equipment | 89 | 79 | 63 | 38 | 15 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 5 | 4 | 3 | 2 | 2 |
Deposits & Other Assets | 0 | 0 | 0 | 0 | 0 |
Total Assets | 197 | 195 | 208 | 201 | 155 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 29 | 22 | 22 | 22 | 19 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 2 |
Current Portion Capital Leases | 2 | 1 | 2 | 1 | 0 |
Accrued Expenses | 0 | 0 | 0 | 0 | 0 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 30 | 24 | 24 | 23 | 21 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 47 | 46 | 45 | 32 | 2 |
Non-Current Capital Leases | 21 | 20 | 21 | 21 | 0 |
Other Non-Current Liabilities | 3 | 5 | 6 | 3 | 0 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 101 | 94 | 95 | 78 | 22 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 377 | 360 | 343 | 326 | 312 |
Retained Earnings | -281 | -260 | -231 | -204 | -180 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 96 | 101 | 113 | 123 | 132 |
Total Liabilities & Shareholder's Equity | 197 | 195 | 208 | 201 | 155 |
Total Common Equity | 96 | 101 | 113 | 123 | 132 |
Shares Outstanding | 43.00 | 42.20 | 41.50 | 40.60 | 39.40 |
Book Value Per Share | 2.22 | 2.39 | 2.71 | 3.03 | 3.35 |
Fiscal Year End for AxoGen, Inc falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 27 | 24 | 37 | 39 | 41 |
Receivables | 25 | 24 | 25 | 23 | 22 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 28 | 28 | 23 | 23 | 21 |
Other Current Assets | 2 | 3 | 3 | 3 | 3 |
Total Current Assets | 82 | 79 | 88 | 87 | 86 |
Net Property & Equipment | 87 | 88 | 89 | 89 | 87 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 5 | 5 | 5 | 4 | 4 |
Deposits & Other Assets | 0 | 0 | 0 | 0 | 0 |
Total Assets | 189 | 187 | 197 | 195 | 192 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 22 | 21 | 29 | 26 | 23 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 2 | 2 | 2 | 1 | 1 |
Accrued Expenses | 0 | 0 | 0 | 0 | 0 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 23 | 23 | 30 | 27 | 24 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 47 | 47 | 47 | 46 | 46 |
Non-Current Capital Leases | 20 | 21 | 21 | 20 | 20 |
Other Non-Current Liabilities | 3 | 3 | 4 | 4 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 93 | 93 | 101 | 97 | 94 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 385 | 381 | 377 | 375 | 370 |
Retained Earnings | -290 | -288 | -281 | -277 | -273 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 96 | 93 | 96 | 98 | 97 |
Total Liabilities & Shareholder's Equity | 189 | 187 | 197 | 195 | 192 |
Total Common Equity | 96 | 93 | 96 | 98 | 97 |
Shares Outstanding | 43.70 | 43.70 | 43.00 | 42.90 | 42.80 |
Book Value Per Share | 2.19 | 2.13 | 2.22 | 2.28 | 2.27 |